Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
2018
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells
2016
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
2011
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Labeling anti-HER2/neu Monoclonal Antibodies with 111 In and 90 Y Using a Bifunctional DTPA Chelating Agent
2003
Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
2009
Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids
2004
EGFR Antagonists in Cancer Treatment
2008 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Antibody therapy for residual disease in acute myelogenous leukemia
2001
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
2010
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
2008
Antibody-targeted radiation cancer therapy
2004
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
2013
An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate‐specific membrane antigen small molecule derivatives
2006
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Cancer Statistics, 2006
2006 Standout
Multiple physiological functions for multidrug transporter P-glycoprotein?
2000
Immunogenic cell death in cancer and infectious disease
2016 Standout
Cancer stem cells revisited
2017 Standout
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization
2007
Design and synthesis of 225Ac radioimmunopharmaceuticals
2002
Delivery technologies for cancer immunotherapy
2019 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Antibody therapy of cancer
2012 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in Mice
2007
Polymer conjugates as anticancer nanomedicines
2006 Standout
Targeting multidrug resistance in cancer
2006 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: Radiolabeling, serum stability, and biodistribution and tumor uptake studies
2013
Complement resistance of tumor cells: basal and induced mechanisms
1999
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Thermodynamic Analysis of Degenerate Recognition by the NKG2D Immunoreceptor
2003
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody
2011
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
2004
Apoptosis
2002 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
2011
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
2017
Immunotherapy for prostate cancer
2006
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice
2009
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Is prostate-specific membrane antigen a multifunctional protein?
2005
Microenvironmental regulation of metastasis
2008 Standout
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
2010
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Production of Multimeric Prostate-Specific Membrane Antigen Small-Molecule Radiotracers Using a Solid-Phase 99mTc Preloading Strategy
2007
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature
2005
Tumor Angiogenesis
2008 Standout
Immunotherapy for prostate cancer
2007
Antitumor Immunity Induced after α Irradiation
2014
Immunogenic peptide discovery in cancer genomes
2015
Renal clearance of quantum dots
2007 StandoutNobel
Mutations Designed to Destabilize the Receptor-Bound Conformation Increase MICA-NKG2D Association Rate and Affinity
2007 StandoutNobel
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen
2005
Evaluation of a Maleimido Derivative of CHX-A′′ DTPA for Site-Specific Labeling of Affibody Molecules
2008
The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis
1998
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
2013
Acute Myeloid Leukemia
2015 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Design, Synthesis, and Characterization of a Dual Modality Positron Emission Tomography and Fluorescence Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging
2007
Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
2013
Synthesis and in Vitro Testing of J591 Antibody−Dendrimer Conjugates for Targeted Prostate Cancer Therapy
2004
A highly effective bifunctional ligand for radioimmunotherapy applications
2011
Triboelectric Nanogenerator: A Foundation of the Energy for the New Era
2018 Standout
Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications
2011
Unconventional nuclides for radiopharmaceuticals.
2010
A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen
2007
Investigational CD33-targeted therapeutics for acute myeloid leukemia
2018
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
2001
Evolutionary trend analysis of nanogenerator research based on a novel perspective of phased bibliographic coupling
2017
Antibody−Dendrimer Conjugates: The Number, Not the Size of the Dendrimers, Determines the Immunoreactivity
2008
Antibody therapy for acute myeloid leukaemia
2013
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
2002
Unconventional Nuclides for Radiopharmaceuticals
2010
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
2006
Emerging Therapeutics for Alzheimer's Disease
2014
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Enhanced Efficacy of Radioimmunotherapy with 90Y-CHX-A″-DTPA-hu3S193 by Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling with EGFR Tyrosine Kinase Inhibitor AG1478
2005
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
2004
Bifunctional chelates for metal nuclides.
2008
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
2003
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Novel Bimodal Bifunctional Ligands for Radioimmunotherapy and Targeted MRI
2008
Acute myeloid leukaemia
2016
Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
2014
Radiometals for Combined Imaging and Therapy
2012
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
2000
Works of Michael Curcio being referenced
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2014
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies
1995
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
2013
The multidrug resistance phenotype confers immunological resistance.
1996
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
1999
Tumor Therapy with Targeted Atomic Nanogenerators
2001 Science
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity
1995
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
2000